Skip to main navigation
Skip to search
Skip to main content
UTMB Health Research Expert Profiles Home
Help & FAQ
Link opens in a new tab
Search content at UTMB Health Research Expert Profiles
Home
Experts
Departments
Equipment
Projects/Grants
Publications
Activities
Press/Media
Honors
Impacts
Risk of hospitalisation after primary treatment for prostate cancer
Stephen B. Williams
, Zhigang Duan
, Karim Chamie
, Karen E. Hoffman
, Benjamin D. Smith
, Jim C. Hu
, Jay B. Shah
, John W. Davis
, Sharon H. Giordano
Surgery
Research output
:
Contribution to journal
›
Article
›
peer-review
6
Link opens in a new tab
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Risk of hospitalisation after primary treatment for prostate cancer'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Prostate Cancer
100%
Hospitalization
100%
Radical Prostatectomy
100%
Hospitalization Risk
100%
Radiotherapy
83%
Treatment Complications
83%
Odds Ratio
66%
Confidence Interval
66%
Medicare
16%
Comorbidity
16%
Hospital Readmission
16%
Surveillance Epidemiology
16%
Hospital Costs
16%
Logistic Regression Analysis
16%
Treatment-related
16%
No Significant Difference
16%
Definitive Therapy
16%
Associated Costs
16%
Linked Database
16%
Propensity Score
16%
External Beam Radiotherapy
16%
Localized Prostate Cancer
16%
Intensity-modulated Radiotherapy
16%
Intensity-modulated
16%
Weight Analysis
16%
External Beam RT
16%
Bundled Payment Models
16%
Nursing and Health Professions
Prostate Cancer
100%
Prostatectomy
100%
Radiotherapy
83%
Odds Ratio
66%
Confidence Interval
66%
External Beam Radiotherapy
33%
Hospital Readmission
16%
Medicare
16%
Logistic Regression Analysis
16%
Propensity Score
16%
Intensity Modulated Radiation Therapy
16%
Comorbidity
16%
Medicine and Dentistry
Prostate Cancer
100%
Prostatectomy
100%
Radiation Therapy
83%
Odds Ratio
66%
Health Care Cost
33%
External Beam Radiotherapy
33%
Medicare
16%
Surveillance, Epidemiology, and End Results
16%
Logistic Regression Analysis
16%
Intensity Modulated Radiation Therapy
16%
Comorbidity
16%